BioCentury
ARTICLE | Clinical News

Telotristat etiprate: Completed Phase III enrollment

April 13, 2015 7:00 AM UTC

Lexicon completed enrollment of 135 patients inadequately controlled by somatostatin analog therapy in the double-blind, placebo-controlled, international Phase III TELESTAR trial evaluating 250 and 5...